Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004
Pfizer (United States) · National Heart Lung and Blood Institute
Abstract
This study assesses trends in hypertension prevalence, blood pressure distributions and mean levels, and hypertension awareness, treatment, and control among US adults, age >or=18 years, between the third National Health and Nutrition Examination Survey (1988-1994) and the 1999-2004 National Health and Nutrition Examination Survey, a period of approximately 10 years. The age-standardized prevalence rate increased from 24.4% to 28.9% (P
Citation impact
- FWCI
- 55.57
- Percentile
- 100%
- References
- 42
Authors
6- JAJeffrey A. CutlerCorresponding
Pfizer (United States), National Heart Lung and Blood Institute
- PDPaul D. Sorlie
Pfizer (United States), National Heart Lung and Blood Institute
- MWMichael Wolz
Pfizer (United States), National Heart Lung and Blood Institute
- TTThomas Thom
Pfizer (United States), National Heart Lung and Blood Institute
- LELarry E. Fields
Pfizer (United States), National Heart Lung and Blood Institute
Topics & keywords
- Medicine
- National Health and Nutrition Examination Survey
- Demography
- Ethnic group
- Body mass index
- Blood pressure
- Gerontology
- Population
- Good health and well-being